연구성과로 돌아가기

2023 연구성과별 연구자 정보 (837 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Bezerra, Jorge A. Bezerra, JA 2 Univ Texas Southwestern Med Ctr, Dallas, TX USA
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Choe, Byung Ho Choe, BH 3 Kyungpook Natl Univ, Sch Med, Daegu, South Korea KSM-6251-2024 Choe, Byung-Ho 0000-0001-9899-9120 Choe, Byung-Ho
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Choe, Byung Ho Choe, BH 3 Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea KSM-6251-2024 Choe, Byung-Ho 0000-0001-9899-9120 Choe, Byung-Ho
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Lin, Chuan-Hao Lin, CH 4 Childrens Hosp Los Angeles, Los Angeles, CA USA AAH-6563-2019 Lin, Chuan-Hao
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Abramov, Frida Abramov, F 5 Gilead Sci Inc, Foster City, CA USA
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Wang, Hongyuan Wang, HY 6 Gilead Sci Inc, Foster City, CA USA JWP-2279-2024 wang, hongyuan
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Liu, Yang Liu, Y 7 Gilead Sci Inc, Foster City, CA USA
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Flaherty, John F. Flaherty, JF 8 Gilead Sci Inc, Foster City, CA USA
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Pacurar, Daniela Pacurar, D 9 Carol Davila Univ Med & Pharm, Bucharest, Romania IYS-1131-2023 Pacurar, Daniela
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Kim, Kyung Mo Kim, KM 10 Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Khaertynova, Ilsiyar Khaertynova, I 11 Kazan State Med Univ, Kazan, Russia
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Shalimar Shalimar 12 All India Inst Med Sci, Delhi, India
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Wu, Jia-Feng Wu, JF 13 Natl Taiwan Univ Hosp, Taipei, Taiwan KZU-6709-2024 Wu, Jiafeng
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Tandon, Manish Tandon, M 14 MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India
EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) Rosenthal, Philip Rosenthal, P 15 Univ Calif San Francisco, San Francisco, CA 94143 USA
페이지 이동: